<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02288104</url>
  </required_header>
  <id_info>
    <org_study_id>MKT-IR-NHC-2014</org_study_id>
    <nct_id>NCT02288104</nct_id>
  </id_info>
  <brief_title>Needle-based Confocal Laser Endomicroscopy in CT-guided Percutaneous Procedures</brief_title>
  <official_title>Needle-based Confocal Laser Endomicroscopy in CT-guided Procedures in Interventional Radiology With Applications in Liver and Kidneys: a Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mauna Kea Technologies</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mauna Kea Technologies</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective study in order to demonstrate the technical feasibility and
      safety of doing endomicroscopic imaging during interventional radiology procedure in two main
      indications: Kidneys and liver.

      This innovative study will involve the use of probe-based confocal laser endomicroscopy. The
      proposed study is a feasibility study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interventional radiology is a medical sub-specialty of radiology which utilizes
      minimally-invasive image-guided procedures to diagnose and treat diseases in nearly every
      organ. The concept behind interventional radiology is to diagnose and treat patients using
      less invasive techniques currently available in order to minimize risk to the patient and
      improve health outcomes.

      For many years, surgery was the only treatment available for many conditions. Today,
      interventional radiology treatments are frst-line care for a wide variety of conditions.
      Patients should be offered the least invasive option frst. It is important to get a second
      opinion and know all of your treatment options before consenting to any procedure or surgery.
      Interventional radiologists are specialists in minimally invasive treatments, have a unique
      breadth of training and provide consults to every type of specialist.

      Surgical removal of liver tumors offers the best chance for a cure. Unfortunately, liver
      tumors are often inoperable because the tumor may be too large, or has grown into major blood
      vessels or other vital structures. Sometimes, many small tumors are spread throughout the
      liver, making surgery too risky or impractical. Surgical removal is not possible for more
      than two-thirds of primary liver cancer patients and 90 percent of patients with secondary
      liver cancer.

      The objectives of this study are to demonstrate the technical feasibility and safety of doing
      endomicroscopic imaging during interventional radiology procedure in two main indications:
      liver and kidneys.

      The Primary objective is:

      To study and demonstrate the technical feasibility and safety of doing endomicroscopic
      imaging during interventional radiology procedure in two main indications: liver and kidney.

      The Secondary objectives are:

        1. Assess the safety of the use of Endomicroscopic imaging during interventional radiology
           procedure in two main indications: liver and kidney.

        2. Assess the quality of biopsies performed with the help of Cellvizio.

        3. Build a database of images as an atlas and define image interpretation criteria in
           collaboration with pathologists.

      Evaluate whether and how Cellvizio can improve guidance for biopsies or ablations: for
      instance, in the critical structures such as nerves or vessels in the vicinity of the
      cryoablation area, is it possible to visualize ice crystals and therefore decide to stop the
      cryoablation at the right time/location?

      For both applications, technical feedback from the physicians is expected on how they think
      the combined use of the devices could change the care path. E.g. a certain step in the
      workflow might become obsolete or the workflow could lead to fewer patient visits.

      For the safety of this protocol, the use of endomicroscopy will not change in any way the
      patient management and standard procedure, including the diagnosis nor treatment decisions.
      All the adverse events / serious adverse events will be noted during the procedure and one
      week after the procedure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">March 17, 2017</completion_date>
  <primary_completion_date type="Actual">March 17, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic accuracy (sensitivity specificity) of endomicroscopy as compared to histopathology</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>Assessment of the accuracy of Cellvizio confocal mini probe imaging guided by fluoroscopy at the tumor boundary compared with traditional histopathology from physical biopsies</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure adverse events frequency in the use of mini probes on the tumor</measure>
    <time_frame>Up to 1 week</time_frame>
    <description>Assessment of the safety of inserting Cellvizio confocal miniprobe in the tumor (nor increase in bleeding or tumor cell dissemination) through the frequency, type and severity of adverse events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Classification of endomicroscopy images from benign and malignant conditions</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>A first creation of an atlas of endomicroscopic images obtained in interventional radiology with corresponding correlation with traditional pathology images</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of biopsies guided by nCLE (needle-based Confocal Laser Endomicroscopy) which provide a definitive diagnosis as a measure of efficiency of endomicroscopy-targeted biopsies compared to traditional needle biopsies</measure>
    <time_frame>Up to 5 months</time_frame>
    <description>Yield of nCLE (needle-based confocal laser endomicroscopy)-targeted Fluoroscopy-guided biopsies to assess improvements compared to standard of care from guidance function of the device combination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients for whom endomicroscopy could have affected the clinical workflow</measure>
    <time_frame>Up to 5 months</time_frame>
    <description>Evaluation of the potential impact of the endomicroscopic information used in conjunction with the Siemens SOMATOM Definition system in clinical decision-making for each patient</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Liver Percutaneous Biopsy or Ablation</condition>
  <condition>Kidney Percutaneous Biopsy or Ablation</condition>
  <arm_group>
    <arm_group_label>needle based confocal endomicroscopy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The patient, scheduled for a standard liver or kidney percutaneous biopsy or ablation will undergo a needle-based confocal laser endomicroscopy procedure during the procedure. The objectives of this study are to demonstrate the technical feasibility and safety of doing endomicroscopic imaging during interventional radiology procedure and determine whether it is technically feasible to obtain images from Cellvizio during an interventional radiology procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>needle based confocal endomicroscopy</intervention_name>
    <description>real time imaging of living tissue at microscopic scale, through a needle.</description>
    <arm_group_label>needle based confocal endomicroscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled to have an interventional radiology procedure for needle-biopsy or
             radiofrequency ablation purposes in liver or Kidney.

          -  Only subjects who have provided written informed consent for the study can be included
             in the study.

        Exclusion Criteria:

          -  Patients have a known allergy to fluorescein

          -  Patient is Pregnant or breast-feeding

          -  Patient under judiciary control

          -  Patient under the tutelage of a guardian

          -  Patient unable to sign the information consent form (in case of an emergency situation
             or difficulty in understanding the information)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Afshin Gangi</last_name>
    <role>Principal Investigator</role>
    <affiliation>NHC, Strasbourg, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nouvel HÃ´pital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2014</study_first_submitted>
  <study_first_submitted_qc>November 6, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2014</study_first_posted>
  <last_update_submitted>August 28, 2017</last_update_submitted>
  <last_update_submitted_qc>August 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Interventional Radiology</keyword>
  <keyword>Liver</keyword>
  <keyword>Kidney</keyword>
  <keyword>Confocal endomicroscopy</keyword>
  <keyword>Optical Biopsy</keyword>
  <keyword>Scanner</keyword>
  <keyword>Fluoroscopy</keyword>
  <keyword>CT</keyword>
  <keyword>Computed Tomography</keyword>
  <keyword>Radiofrequency Ablation</keyword>
  <keyword>Fluorescein</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

